IvanMarquesBorrelloMD

Hematologic Oncology

Associate Professor of Oncology, Johns Hopkins University School of Medicine

Dr. Borrello is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2 Tampa General Cir
Fl 3
Tampa, FL 33606
Phone+1 813-844-7585

Fax+1 443-287-4653

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1995 - 1998
University of ChicagoResidency, Internal Medicine, 1992 - 1995
Virginia Commonwealth University School of MedicineClass of 1992

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

PubMed

33 citations
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas
Jian Campian, Xiaobu Ye, Douglas E. Gladstone, Prakash Ambady, Thomas R. Nirschl
Journal of Neuro-Oncology. 2015-06-13
981 citations
Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America
Donna M. Weber, Christine Chen, Ruben Niesvizky, Michael Wang, Andrew Belch
The New England Journal of Medicine. 2007-11-22
1381 citations
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
Leo Luznik, Paul O'Donnell, Heather J. Symons, Allen R. Chen, M. Susan Leffell
Biology of Blood and Marrow Transplantation. 2008-06-01

Abstracts/Posters

Superior Efficacy of CAR-T Cells Using Marrow-Infiltrating Lymphocytes (MILsTM) As Compared to Peripheral Blood Lymphocytes (PBLs)
Ivan M. Borrello, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Immunotherapy in Myeloma
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Tampa General Hospital’s New Bone Marrow Transplant and Cell Therapies Unit Saved a Palm Beach County Patient’s LifeApril 1st, 2023
5 Oncologists on the MoveJanuary 9th, 2023
World-Renowned Myeloma Expert, Dr. Ivan Borrello, Joins TGH Cancer Institute to Lead Its Bone Marrow Transplant (BMT)and Cell Therapies ProgramDecember 9th, 2022
Join now to see all

The Role Of Myeloid Suppressor Cells In Tumor-Specific ToleranceNational Cancer Institute2007–2011
Marrow Infiltrating Lymphocyte Immunotherapy In MyelomaNational Cancer Institute2008–2009
Tumor Vaccines In Autologous Bone Marrow TransplantationNational Cancer Institute2001–2005